?
z.B. 0-20
?
z.B. 0-15
?
z.B. 0-5
?
z.B. 0-3
Aktien Screener
Filter & Suche
518 Ergebnisse (1 aktive Filter)
Die Kennzahlen-Filter werden aktiviert, sobald die vollständige Liste geladen ist.
Suchergebnisse
518 Unternehmen gefunden • Seite 1 von 21
? | ? | ? | ? | ? | ? | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Novo Nordisk A/S | 96.2 | Arzneimittel (Pharmazeutisch) | Dänemark | 189.3 Mrd. USD | 10.49 | 24.97 | 3.71 | 5.52 | ▲ 19.48% | ▲ 19.44% | 4.09% | ▲ 16.47% | - | 33.14% | ▲ 0.18% | 41.30% | ▲ 0.12% | 9.38% | ▼ -6.11% | 6 / 9 | 2,93 | 40-fach | 46 / 100 | −3,1 / 100 | −2,74 |
 | Eli Lilly and Company | 95.4 | Arzneimittel (Pharmazeutisch) | USA | 994.9 Mrd. USD | 37.25 | 49.61 | 12.49 | 29.37 | ▲ 21.58% | ▲ 27.22% | 0.62% | ▲ 15.27% | 11 Jahre | 31.67% | ▲ 2.55% | 45.56% | ▲ 4.36% | 13.77% | ▼ -2.57% | 7 / 9 | 3,81 | 23-fach | 49 / 100 | 3,4 / 100 | −1,92 |
 | Shan Dong Dong-E E-Jiao Co Ltd | 86.5 | Arzneimittel (Pharmazeutisch) | China | 4.4 Mrd. USD | 16.46 | 26.59 | 4.31 | 2.89 | ▲ 14.27% | ▲ 109.30% | 5.87% | ▲ 34.57% | - | 26.17% | ▲ 3.65% | 29.21% | ▲ 3.75% | 34.67% | ▼ -9.18% | 7 / 9 | 10,61 | > 50-fach | 36 / 100 | −4,8 / 100 | −3,50 |
 | Johnson & Johnson | 86.3 | Arzneimittel (Pharmazeutisch) | USA | 640.0 Mrd. USD | 30.42 | 34.21 | 6.54 | 7.53 | ▲ 2.67% | ▲ 12.74% | 2.02% | ▲ 4.80% | 41 Jahre | 28.46% | ▼ -0.27% | 27.17% | ▼ -0.02% | 20.91% | ▼ -0.75% | 5 / 9 | 4,67 | 23-fach | 34 / 100 | 1,1 / 100 | −2,52 |
| Shenyang Xingqi Pharmaceutical Co Ltd | 85.9 | Arzneimittel (Pharmazeutisch) | China | 1.9 Mrd. USD | 16.01 | 493.80 | 4.68 | 5.86 | ▲ 29.13% | ▲ 51.23% | 4.15% | ▲ 73.93% | - | 28.14% | ▲ 1.89% | 34.12% | ▲ 2.18% | 19.53% | ▲ 1.01% | 8 / 9 | 7,94 | > 50-fach | 79 / 100 | −2,3 / 100 | −2,81 |
 | Zoetis Inc | 85.3 | Arzneimittel (Pharmazeutisch) | USA | 30.1 Mrd. USD | 11.53 | 12.74 | 3.17 | 9.58 | ▲ 7.24% | ▲ 10.29% | 2.91% | ▲ 16.22% | 12 Jahre | 28.23% | ▲ 0.48% | 38.00% | ▲ 0.43% | 24.12% | ▲ 1.20% | 8 / 9 | 6,67 | 14-fach | 43 / 100 | −1,5 / 100 | −2,48 |
| Hunan Jiudian Pharmaceutical Co Ltd | 84.7 | Arzneimittel (Biotechnologie) | China | 0.8 Mrd. USD | 15.37 | - | 1.82 | 2.02 | ▲ 26.04% | ▲ 41.87% | 3.82% | ▲ 78.72% | 5 Jahre | 15.20% | ▲ 1.12% | 18.75% | ▲ 1.68% | -0.19% | ▲ 0.97% | 4 / 9 | 6,37 | 35-fach | 58 / 100 | −4,5 / 100 | −4,29 |
| Consun Pharmaceutical Group | 84.4 | Arzneimittel (Pharmazeutisch) | China | 1.4 Mrd. USD | 8.02 | 7.73 | 2.59 | 1.96 | ▲ 14.29% | ▲ 16.67% | 5.98% | ▲ 30.60% | - | 31.55% | ▲ 0.69% | 35.18% | ▲ 0.39% | 33.46% | ▲ 0.02% | 7 / 9 | 9,93 | > 50-fach | 44 / 100 | −2,2 / 100 | −0,48 |
| Zhejiang Jolly Pharmaceutical Co Ltd | 84.3 | Arzneimittel (Pharmazeutisch) | China | 1.4 Mrd. USD | 14.58 | - | 2.88 | 2.78 | ▲ 22.76% | ▲ 48.06% | 2.66% | ▲ 28.47% | - | 20.78% | ▲ 2.15% | 26.21% | ▲ 2.65% | 4.10% | ▼ -1.25% | 6 / 9 | 5,57 | > 50-fach | 40 / 100 | 4,7 / 100 | −3,19 |
 | Vertex Pharmaceuticals Inc | 83.8 | Arzneimittel (Biotechnologie) | USA | 130.6 Mrd. USD | 29.66 | 34.42 | 10.35 | 6.45 | ▲ 14.24% | ▲ 7.83% | - | - | - | 32.74% | ▼ -3.84% | 39.43% | ▼ -4.50% | 26.45% | ▼ -6.18% | 7 / 9 | 7,35 | > 50-fach | 39 / 100 | 1,2 / 100 | −2,16 |
| Amoy Diagnostics Co Ltd | 83.3 | Arzneimittel (Biotechnologie) | China | 1.0 Mrd. USD | 19.43 | 129.15 | 5.53 | 3.44 | ▲ 10.46% | ▲ 14.69% | 2.70% | ▲ 26.51% | 2 Jahre | 29.88% | ▼ -0.08% | 34.87% | ▲ 0.68% | 24.60% | ▲ 4.76% | 8 / 9 | 15,76 | > 50-fach | 42 / 100 | −0,3 / 100 | −3,03 |
| China Shineway Pharmaceutical Group Ltd | 82.7 | Arzneimittel (Pharmazeutisch) | China | 0.8 Mrd. USD | 6.44 | 4.84 | 1.94 | 0.63 | ▲ 3.38% | ▲ 26.35% | 17.86% | ▲ 14.72% | - | 30.30% | ▲ 3.00% | 21.75% | ▲ 1.46% | 31.07% | ▲ 2.13% | 7 / 9 | 10,29 | > 50-fach | 21 / 100 | −2,1 / 100 | −2,72 |
 | Chugai Pharmaceutical Co. Ltd | 82.7 | Arzneimittel (Pharmazeutisch) | Japan | 70.4 Mrd. USD | 22.89 | 26.68 | 8.03 | 5.38 | ▲ 9.85% | ▲ 15.13% | 2.02% | ▲ 8.70% | 2 Jahre | 34.50% | ▲ 1.18% | 46.92% | ▲ 1.34% | 24.90% | ▲ 2.83% | 5 / 9 | 12,46 | > 50-fach | 36 / 100 | 1,8 / 100 | −2,04 |
 | Daiichi Sankyo Company Limited | 82.4 | Arzneimittel (Pharmazeutisch) | Japan | 32.1 Mrd. USD | 20.29 | - | 2.22 | 2.92 | ▲ 17.29% | ▲ 28.05% | 3.61% | ▲ 18.10% | 1 Jahre | 12.24% | ▲ 1.88% | 9.76% | ▲ 1.37% | -2.39% | ▼ -2.75% | 5 / 9 | 4,52 | 34-fach | 36 / 100 | 4,6 / 100 | −1,99 |
| Henan Lingrui Pharmaceutical Co Ltd | 81.7 | Arzneimittel (Pharmazeutisch) | China | 1.6 Mrd. USD | 13.83 | 118.03 | 2.77 | 3.34 | ▲ 10.57% | ▲ 18.47% | 5.78% | ▲ 22.42% | 6 Jahre | 19.71% | ▲ 1.77% | 21.76% | ▲ 1.71% | 12.90% | ▼ -3.65% | 5 / 9 | 4,13 | > 50-fach | 55 / 100 | 3,7 / 100 | −3,82 |
 | Merck & Company Inc | 81.6 | Arzneimittel (Pharmazeutisch) | USA | 355.1 Mrd. USD | 111.91 | 22.11 | 5.35 | 8.47 | ▲ 9.35% | ▲ 20.90% | 2.36% | ▲ 5.51% | 15 Jahre | 28.12% | ▲ 0.48% | 36.17% | ▲ 1.88% | 19.04% | ▲ 0.18% | 4 / 9 | 4,23 | 12-fach | 34 / 100 | 1,3 / 100 | −2,24 |
 | WuXi AppTec Co Ltd H | 81.3 | Arzneimittel (Biotechnologie) | China | 72.8 Mrd. USD | 22.29 | 36.98 | 9.14 | 5.87 | ▲ 22.42% | ▲ 45.34% | 1.27% | - | - | 42.23% | ▲ 4.16% | 37.41% | ▲ 2.45% | 25.66% | ▲ 9.16% | 8 / 9 | 9,43 | > 50-fach | 21 / 100 | 1,9 / 100 | −2,54 |
| Chengdu Kanghong Pharmaceuticals Group Co Ltd | 80.7 | Arzneimittel (Pharmazeutisch) | China | 2.6 Mrd. USD | 17.55 | 102.24 | 4.06 | 1.90 | ▲ 6.83% | - | 3.68% | ▲ 47.58% | 3 Jahre | 25.36% | ▲ 2.77% | 28.26% | ▲ 3.79% | 27.07% | ▲ 6.96% | 6 / 9 | 22,24 | > 50-fach | 41 / 100 | −3,4 / 100 | −2,91 |
 | United Therapeutics Corporation | 80.5 | Arzneimittel (Biotechnologie) | USA | 21.3 Mrd. USD | 16.26 | 19.51 | 6.76 | 3.33 | ▲ 16.50% | ▲ 20.99% | - | - | - | 41.94% | ▲ 3.14% | 47.67% | ▲ 2.66% | 32.70% | ▲ 1.20% | 8 / 9 | 17,14 | 38-fach | 36 / 100 | −2,9 / 100 | −2,27 |
 | Incyte Corporation | 80.2 | Arzneimittel (Biotechnologie) | USA | 24.6 Mrd. USD | 15.27 | 12.82 | 4.23 | 3.88 | ▲ 14.03% | - | - | - | - | 25.03% | ▼ -2.27% | 26.12% | ▼ -0.20% | 26.35% | ▼ -0.58% | 9 / 9 | 8,02 | > 50-fach | 68 / 100 | −1,8 / 100 | −2,42 |
 | Samsung Biologics Co Ltd | 80.0 | Arzneimittel (Biotechnologie) | Südkorea | 45.9 Mrd. USD | 33.01 | 41.60 | 14.41 | 7.83 | ▲ 31.37% | ▲ 49.25% | - | - | - | 39.16% | ▲ 3.25% | 45.41% | ▲ 2.73% | 16.96% | ▲ 3.59% | 9 / 9 | 6,61 | 33-fach | 23 / 100 | −4,2 / 100 | - |
 | Neurocrine Biosciences Inc | 80.0 | Arzneimittel (Biotechnologie) | USA | 15.9 Mrd. USD | 22.51 | 18.35 | 4.71 | 4.30 | ▲ 22.29% | ▲ 3.28% | - | - | - | 16.73% | ▲ 2.18% | 21.64% | ▲ 3.27% | 26.17% | ▲ 1.32% | 7 / 9 | 6,34 | 13-fach | 61 / 100 | −6,6 / 100 | −2,58 |
| Jiangsu Hengrui Medicine Co Ltd | 79.4 | Arzneimittel (Pharmazeutisch) | China | 42.2 Mrd. USD | 36.65 | 76.85 | 9.04 | 4.39 | ▲ 2.53% | ▲ 4.03% | 0.38% | ▲ 16.29% | - | 24.53% | ▲ 1.84% | 25.51% | ▲ 2.24% | 26.49% | ▲ 5.62% | 5 / 9 | 15,40 | > 50-fach | 39 / 100 | −5,2 / 100 | −3,08 |
 | Novartis AG | 79.2 | Arzneimittel (Pharmazeutisch) | Schweiz | 260.5 Mrd. USD | 20.60 | 16.32 | 4.76 | 6.26 | ▲ 2.74% | ▲ 12.66% | 3.30% | ▲ 4.28% | 29 Jahre | 25.64% | ▼ -5.09% | 31.15% | ▲ 2.64% | 32.27% | ▲ 0.96% | 7 / 9 | 3,22 | 14-fach | 37 / 100 | −4,7 / 100 | −2,55 |
| Zhejiang Nhu Co Ltd | 79.1 | Arzneimittel (Pharmazeutisch) | China | 12.1 Mrd. USD | 11.36 | - | 3.36 | 2.34 | ▲ 16.62% | ▲ 13.67% | 3.77% | ▲ 10.48% | 1 Jahre | 30.40% | ▲ 0.68% | 35.85% | ▲ 0.83% | 31.00% | ▲ 5.92% | 8 / 9 | 7,48 | 23-fach | 22 / 100 | −4,5 / 100 | −2,76 |
